These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24231121)

  • 1. Interaction of vitamin K antagonists and trimethoprim-sulfamethoxazole: ignore at your patient's risk.
    Hale SF; Lesar TS
    Drug Metabol Drug Interact; 2014; 29(1):53-60. PubMed ID: 24231121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to optimal dosing of vitamin K antagonists.
    Witt DM
    Semin Thromb Hemost; 2012 Oct; 38(7):667-72. PubMed ID: 22893509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens.
    Glasheen JJ; Fugit RV; Prochazka AV
    J Gen Intern Med; 2005 Jul; 20(7):653-6. PubMed ID: 16050864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.
    Pyle RC; Butterfield JH; Volcheck GW; Podjasek JC; Rank MA; Li JT; Harish A; Poe KL; Park MA
    J Allergy Clin Immunol Pract; 2014; 2(1):52-8. PubMed ID: 24565769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
    Grim SA; Rapp RP; Martin CA; Evans ME
    Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suspected trimethoprim/sulfamethoxazole-induced hypoprothrombinemia.
    Cook DE; Ponte CD
    J Fam Pract; 1994 Dec; 39(6):589-91. PubMed ID: 7798864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital admission due to warfarin potentiation by TMP-SMX.
    Chafin CC; Ritter BA; James A; Self TH
    Nurse Pract; 2000 Dec; 25(12):73-5. PubMed ID: 11149144
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacoepidemiological assessment of drug interactions with vitamin K antagonists.
    Pottegård A; dePont Christensen R; Wang SV; Gagne JJ; Larsen TB; Hallas J
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1160-7. PubMed ID: 25250949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of preemptive warfarin dose reduction on anticoagulation after initiation of trimethoprim-sulfamethoxazole or levofloxacin.
    Ahmed A; Stephens JC; Kaus CA; Fay WP
    J Thromb Thrombolysis; 2008 Aug; 26(1):44-8. PubMed ID: 17985084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The interaction between anticoagulant therapy with vitamin K-antagonists and treatment with antibiotics: a practical recommendation].
    Zelis M; Zweegman S; van der Meer FJ; Kramer MH; Smulders YM
    Ned Tijdschr Geneeskd; 2008 May; 152(18):1042-6. PubMed ID: 18547025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole (TMP/SMX) potentiates indinavir nephrotoxicity.
    de Araujo M; Seguro AC
    Antivir Ther; 2002 Sep; 7(3):181-4. PubMed ID: 12487385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of vitamin K antagonist overcoagulation. A case-control study in unselected patients referred to an emergency department.
    Cadiou G; Varin R; Levesque H; Grassi V; Benichou J; Tiret I; Dieu B; Lecam-Duchez V; Borg JY; Muller JM; Benhamou Y; Marie I
    Thromb Haemost; 2008 Oct; 100(4):685-92. PubMed ID: 18841293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim-sulfamethoxazole-induced aseptic meningitis-not just another sulfa allergy.
    Bruner KE; Coop CA; White KM
    Ann Allergy Asthma Immunol; 2014 Nov; 113(5):520-6. PubMed ID: 25240332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient.
    Roustit M; Blondel E; Villier C; Fonrose X; Mallaret MP
    Ann Pharmacother; 2010 Apr; 44(4):764-7. PubMed ID: 20197475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescriptions for a toxic combination: use of methotrexate plus trimethoprim-sulfamethoxazole in the United States.
    Davis SA; Krowchuk DP; Feldman SR
    South Med J; 2014 May; 107(5):292-3. PubMed ID: 24937727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole.
    Feola DJ; Garvy BA; Rapp RP; Thornton AC
    Pharmacotherapy; 2007 Jul; 27(7):937-47. PubMed ID: 17594199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible trimethoprim/sulfamethoxazole-induced aseptic meningitis.
    Therrien R
    Ann Pharmacother; 2004 Nov; 38(11):1863-7. PubMed ID: 15367724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries.
    Mosholder AD; Racoosin JA; Young S; Wernecke M; Shoaibi A; MaCurdy TE; Worrall C; Kelman JA
    Ann Pharmacother; 2013 Nov; 47(11):1420-8. PubMed ID: 24285759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of vitamin K antagonist overcoagulation.
    Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
    QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.